Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples